Navigation Links
Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health, First-Ever Leading Calcium Supplement to Help Support Bone AND Heart Health
Date:11/5/2009

MORRISTOWN, N.J., Nov. 5 /PRNewswire/ -- Bone strength and heart health are two of the most important health issues for women. One out of every two women will have an osteoporosis-related fracture in her lifetime and more than 50 million women have blood cholesterol levels high enough to pose a risk for heart disease. Now there is a new product available to help address both of these issues at the same time. Citracal® Calcium plus Heart Health is the first and only leading calcium supplement that helps support both bone and heart health every day.*

"Calcium and vitamin D are critical for bone health, yet most women aren't always getting enough of these important nutrients," said Julie Upton, MS, RD. "I'm excited that women now have a new option that helps ensure they get enough calcium and vitamin D, as well as natural plant sterols, which may help to reduce their risk of heart disease, the No. 1 killer of women."

New Citracal Calcium plus Heart Health contains 1,260 mg of calcium per daily dose, more than any other leading brand, and has an advanced levels of vitamin D to support calcium absorption.* It also contains Phytosterols, a natural plant ingredient that may reduce the risk of heart disease by lowering cholesterol. +

"We strive to continue to develop new and innovative products to meet our consumers' changing concerns," says Angela Vann, Senior Brand Manager - Citracal. "Women need to attend to bone and heart health daily, and this product conveniently allows them to address both of these important health issues at the same time."

New Citracal plus Heart Health is available at food, mass and drug retail outlets nationwide. For more information visit www.Citracal.com.

About Citracal®

Citracal® has earned the recognition and respect of the medical community, and many physicians recommend Citracal for supplemental
'/>"/>

SOURCE Bayer Consumer Care
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... development and sale of patented biopharmaceutical medicine, modernized traditional ... (API) today announced the business and development progress at ... 1. Following the September 2014 JCM application (No. 51268) ...
(Date:1/22/2015)... Jan. 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" ... on Omega-3 therapies for cardiovascular disease and overall health is ... accomplishments in 2014 and its outlook for 2015 from the ... Shareholders, We would like to take this opportunity ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... "Infectious Disease Diagnostics Market by Product, Application, Technology, ... to their offering. , The infectious disease ... 7.9% to reach $18,156.2 million by 2019 from $12,422.8 ...
Breaking Medicine Technology:TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 2Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 3
... Boston Scientific Corporation (NYSE: BSX ) ... Foundation of America (AAFA) to support education initiatives designed ...  The Company,s support coincides with Asthma and Allergy Awareness ... more than 20 million Americans suffer from asthma -- ...
... PARIS, May 10, 2011 Groupe Hospitalier Pitie ... largest medical centers has continued its long tradition ... radiation therapy with the acquisition of Leksell Gamma ... Perfexion – Paris,s first and only dedicated radiosurgery ...
Cached Medicine Technology:Boston Scientific Supports Asthma Awareness Month With Donation to Asthma Foundation 2Boston Scientific Supports Asthma Awareness Month With Donation to Asthma Foundation 3Boston Scientific Supports Asthma Awareness Month With Donation to Asthma Foundation 4First-ever Gamma Knife in Paris Offers New Treatment Options for Patients With Cancer and Other Brain Disorders 2First-ever Gamma Knife in Paris Offers New Treatment Options for Patients With Cancer and Other Brain Disorders 3
(Date:1/22/2015)... TX (PRWEB) January 22, 2015 The Incredible ... Bodybuilder Ben Pakulski to increase lean muscle by up to ... has caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an ... that it is a step-by-step, scientific diet formula that allows ...
(Date:1/22/2015)... The federal court overseeing thousands of vaginal ... Southern District of West Virginia has upheld a $2 million ... bellwether trial. In an Order dated January 21st, the Court ... that C.R. Bard had not proven a miscarriage of justice. ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining the ... . , Auto insurance quotes help many drivers find ... necessary to call an agent or visit an agency for ... single website: http://autocarinsurancebest.com/ . , Every business who relies ...
(Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... American College of Sports Medicine flagship journal Medicine ... supplementation with L-Citrulline before exercise may help reduce ... strenuous exercise. 1 , Participants in the ...
(Date:1/22/2015)... Colorado (PRWEB) January 22, 2015 Four years since ... Queen – which coincided with the marriage of Avasa & Matthew ... THE ROAD, which is scheduled for release through White Swan Records ... message that there is a sacred path available to all of ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
... program addresses growing mental health workforce,crisis, SAN ... mental health workforce crisis, California Institute of Integral,Studies ... in,Community Mental Health in fall 2008., The ... with a,concentration in Community Mental Health, as well ...
... WASHINGTON, Jan. 29 - The American Red Cross,recently ... called Change a Life, which includes print, television, ... The Change a Life campaign demonstrates how ... consumer, donor and internal research,informed the campaign, which ...
... Incorporated,(NYSE: AFL ) announced today that it ... million shares of its common stock in the,first ... be funded,with internal capital., (Logo: http://www.newscom.com/cgi-bin/prnh/20041202/CLTH019LOGO ... repurchase activities, the board of,directors today authorized the ...
... Fla., Jan. 29 NovaVision, Inc. today,announced that ... the 17th,annual Florida Venture Capital Conference (January 29 ... Petersburg, Florida. During the conference Navroze,Mehta, president and ... audience of more than 200 venture capitalists, investment ...
... 29, 2008) -- An enzyme released by mast cells in ... tightening of airways that is a hallmark of asthma -- ... illness. , Reporting in the online edition of Proceedings of ... Medical College explains that during an immune response, mast cells ...
... also lower than researchers anticipated , , TUESDAY, Jan. 29 ... real-life effectiveness of two different drug-coated stents, Danish researchers ... a lower rate of problems than had been anticipated. ... who had these flexible tubes implanted to help keep ...
Cached Medicine News:Health News:California Institute of Integral Studies Launches Groundbreaking Community Mental Health Program 2Health News:California Institute of Integral Studies Launches Groundbreaking Community Mental Health Program 3Health News:American Red Cross Launches 2008 National Public Service Advertising Campaign 2Health News:Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1% 2Health News:Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1% 3Health News:Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1% 4Health News:NovaVision to be Featured at 2008 Florida Venture Capital Conference 2Health News:Lungs' mast cells could provide new treatment target for asthma, other respiratory disease 2Health News:Lungs' mast cells could provide new treatment target for asthma, other respiratory disease 3Health News:Study Finds Both Coated Stents Perform the Same 2Health News:Study Finds Both Coated Stents Perform the Same 3
Substrate Plasma for Factor X Assay by STA© Analyzers. Freeze-dried human plasma from which factor X has been removed by selective immuno-adsorption....
Immuno-turbidimetric Assay of von Willebrand Factor (vWF) Antigen by STA© Analyzers. Microlatex particles coated with rabbit anti-human vWF antibodies....
Enzyme Immunoassay of Factor IX Antigen by ELISA Method, 96 tests....
Enzyme Immunoassay of -Thromboglobulin Antigen by ELISA Method, 96 tests....
Medicine Products: